The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta

$63,239,785

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

to ARCTURUS THERAPEUTICS, INC.

biotechactive
ACTION DATE2026-03-20·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50122C00007_7505_-NONE-_-NONE-
Award description

PROCURE A PANDEMIC INFLUENZA VACCINE (PANDFLU) AND A QUADRIVALENT SEASONAL INFLUENZA VACCINE (QSFLU)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high
In plain English

Procure pandemic and seasonal influenza vaccines for U.S. pandemic preparedness stockpiles.

Sub-sectors
vaccine-developmentpandemic-preparednessinfluenza-vaccines
Why this matters

Secures domestic vaccine supply capacity for pandemic response, reducing reliance on foreign manufacturers during health emergencies.

Supply-chain signal

Signals sustained government demand for mRNA and viral vector vaccine manufacturing capacity; supports domestic production scale-up.

U.S.–China competition angle

Reduces U.S. dependence on Chinese pharmaceutical supply chains for critical pandemic vaccines; strengthens domestic biotech resilience.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002160.

Period of performance
Start
2022-09-01
End
2026-08-20
Status
activein 96 days
Sources

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.